<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04260139</url>
  </required_header>
  <id_info>
    <org_study_id>Beren Hac覺m</org_study_id>
    <nct_id>NCT04260139</nct_id>
  </id_info>
  <brief_title>Lymph Node Yield in Colon Cancer Resection Specimens</brief_title>
  <official_title>Macroscopic Evaluation of Colon Cancer Resection Specimens to Predict Metastatic Lymph Node Yield</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Bagcilar Training and Research Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Bagcilar Training and Research Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      In this study, we aimed to develop a predictive model of lymph node yield in a series of
      colon cancer resection specimens with detailed anatomic and surgical technique data.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Lymph node yield in colon resection specimens has been associated with the accuracy of
      staging and cancer outcomes. It has been proposed that the more central the mesenteric
      vascular ligation, the greater the nodal yield. However, the optimal number of harvested
      nodes is still a matter of debate. We prospectively evaluated the relation between specimen
      properties such as lenght, area, tumor location and pedicle length to the number of harvested
      nodes and rate of node positivity.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">February 15, 2020</start_date>
  <completion_date type="Anticipated">September 15, 2020</completion_date>
  <primary_completion_date type="Anticipated">June 15, 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Lymph Node Yield in Colon Cancer Resection Specimens</measure>
    <time_frame>September 2019- November 2020</time_frame>
    <description>Count of lymph node</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Lymph Node Yield in Colon Cancer Resection Specimens</measure>
    <time_frame>September 2019-November 2020</time_frame>
    <description>Involvement of lymph node</description>
  </primary_outcome>
  <enrollment type="Anticipated">8</enrollment>
  <condition>Colon Cancer</condition>
  <condition>Lymph Node Metastases</condition>
  <eligibility>
    <study_pop>
      <textblock>
        The pathology specimens from colon neoplasm resections will be prepared so that the lymph
        nodes will be separated according to their anatomic relationship to the vascular pedicles
        and to the tumor. Prior to dissection, the specimen will be measured from all colonic tumor
        patients.
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

        The surgical patients with a histologic diagnosis of colonic neoplasm

        Exclusion Criteria:

          -  rectal or rectosigmoid cancer patients younger than 18 previous colon resection
             emergency colon resection familial adenomatous polyposis or ulcerative colitis
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Bagc覺lar Training and Research Hospital</name>
      <address>
        <city>Istanbul</city>
        <country>Turkey</country>
      </address>
    </facility>
    <contact>
      <last_name>Nadir Adnan Hac覺m, MD.</last_name>
      <phone>+905052607105</phone>
      <email>adnanhcm@hotmail.com</email>
    </contact>
  </location>
  <location_countries>
    <country>Turkey</country>
  </location_countries>
  <verification_date>February 2020</verification_date>
  <study_first_submitted>February 5, 2020</study_first_submitted>
  <study_first_submitted_qc>February 5, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">February 7, 2020</study_first_posted>
  <last_update_submitted>February 8, 2020</last_update_submitted>
  <last_update_submitted_qc>February 8, 2020</last_update_submitted_qc>
  <last_update_posted type="Actual">February 11, 2020</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Bagcilar Training and Research Hospital</investigator_affiliation>
    <investigator_full_name>Nadir Adnan Hac覺m</investigator_full_name>
    <investigator_title>Dr.</investigator_title>
  </responsible_party>
  <keyword>ileocolic pedicle</keyword>
  <keyword>colon cancer</keyword>
  <keyword>Staging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Colonic Neoplasms</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

